In a few short months, the State of Oregon will open up licensing applications for the first state-regulated psilocybin program. Other states – specifically Washington and Colorado – will likely follow suit in the near future. At the same time, ketamine clinics and telehealth operators have proliferated nationally, and a number of groups have made significant progress toward FDA approval of psilocybin, MDMA and other psychedelic drugs.
Over the next few years, there will be an explosion of new psychedelics businesses across the United States. Entrepreneurs and startups need resources to understand how they can act now to protect their intellectual property and business interests.
Harris Bricken and Calyx Law – two of the leading U.S. psychedelics law firms – are teaming up to offer a groundbreaking webinar covering the legal and business landscape in the United States for psychedelics businesses, as well as legal issues for psychedelics startups, including protecting intellectual property, corporate governance, and applications for psilocybin licenses in Oregon and beyond.
Join Griffen Thorne (Harris Bricken, Los Angeles office), Paul Coble (Harris Bricken, Phoenix office), and Graham Pechenik (Calyx Law, San Francisco) for this free 90-minute webinar on Tuesday, October 25th at 12:00 am pacific.
The webinar will be a hybrid presentation with Q&A. The attorneys will answer your questions towards the end of the event, so please feel free to submit your questions in advance. Questions will also be taken throughout the presentation.